Dopamine Receptor D2 (DRD2) Antibody,Abbexa,abx029030

This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia; other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing.

Host

Rabbit

Reactivity

Human

Application

ELISA, WB

Conjugate

Unconjugated

Platform ID

BAB206483124

Abbexa

Headquarters

181 Cambridge Science Park Cambridge, CB4 0GJ United Kingdom

Contact

Tel: +44 (0) 1223 755950
Fax: +44 (0) 1223 755951

Product Specifications

Specifications

NameDopamine Receptor D2 (DRD2) Antibody
Cat. No.abx029030
Accession NumberP14416
Gene ID (Entrez)1813
HostRabbit
IsotypeIgG
ReactivityHuman
ConjugationUnconjugated
ApplicationELISA, WB
Working DilutionsWB: 1/2000. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
Concentration0.5 mg/ml
Molecular WeightCalculated MW: 50.6 kDa
TargetDRD2
ImmunogenKLH-conjugated synthetic peptide between 307-336 amino acids from the C-terminal region of human DRD2.
PurityPurified through a protein A column, followed by peptide affinity purification.
Appearance/FormLiquid
FormulationPBS containing 0.09% sodium azide.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Regulatory StatusResearch Use Only

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.